{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-264143","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.603024+00:00","generated_at":"2026-05-17T00:41:36.163575+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Scilex in-licenses Datavault AI tech for biotech asset tokenization; $10M upfront, $2.55B milestones","bullets":["Worldwide exclusive license from Datavault AI for tokenizing genomic, DNA, diagnostic, therapeutic data in biotech/pharma.","Non-refundable upfront fee $10M payable in four equal $2.5M quarterly installments starting Dec 31, 2025.","Potential sales milestone payments up to $2.55B and 5% royalty on net sales; minimum annual royalty $1M after 24 months.","Core patent includes 'Platform and Method for Tokenizing DNA Data' (U.S. Pat. App. 17/941,623) plus suite of issued/pending patents.","Scilex aims to create a Biotech Exchange platform for secure tokenization, trading, and monetization of biotech assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-264143","json":"https://secwatch.observer/filing/0001193125-25-264143.json","markdown":"https://secwatch.observer/filing/0001193125-25-264143.md","text":"https://secwatch.observer/filing/0001193125-25-264143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/0001193125-25-264143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/sclx-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:41:36.163575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}